Plasma endocannabinoid alterations in individuals with substance use disorder are dependent on the mirror effect of schizophrenia

by Joelle eDesfossés, Emmanuel eStip, Lahcen eAit Bentaleb, Olivier eLipp, Jean-Pierre eChiasson, Alexandra eFurtos, Karine eVenne, Edouard eKouassi, Stephane ePotvin
Published 2012-09-01

Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine

by Simon eZhornitsky, Emmanuel eStip, Joelle eDesfosses, Tania ePampoulova, Elie eRizkallah, Elie eRizkallah, Pierre-Paul eRompre, Lahcen Ait Bentaleb, Olivier eLipp, Jean-Pierre eChiasson, Alain eGendron, Stephane ePotvin
Published 2011-05-01